Aug 14, 2002

New molecular insights into heart failure and cardiomyopathy: potential strategies and therapies

Irish Journal of Medical Science
G A MacGowan, D M McNamara


In the most severely affected patients the mortality for congestive heart failure exceeds that of many cancers. While therapies are largely aimed at attenuating neurohumoral responses recent molecular insights reveal other potential targets for therapy. To summarise some of the recent developments in the management of heart failure and provide the clinician who treats heart failure with new insights into emerging approaches. A literature review was conducted of the recent literature together with personal research data. Large randomised trials will provide a more comprehensive understanding of the interaction of beta-blockers and other heart failure therapies with gene polymorphisms. Cytokines are important in the progression of heart failure, yet therapy aimed at blocking cytokine effects has not been successful. More selective use of anti-cytokine therapy may have beneficial effects. Gene therapy to improve heart failure has not yet reached clinical trials. The molecular genetics of hypertrophic and dilated cardiomyopathy is rapidly improving our understanding so that genetic diagnostics and counselling may soon be performed for patients and families. The emergence of a molecular based understanding of heart failure will hope...Continue Reading

  • References71
  • Citations3


Mentioned in this Paper

Gene Polymorphism
Cardiomyopathy, Familial Idiopathic
Gene Transfer Techniques
Hypertrophic Cardiomyopathy
Hypertrophic Disorder of Skin, Unspecified

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Respiration; International Review of Thoracic Diseases
Y NishimuraM Yokoyama
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology
Gary L PierceRandy W Braith
© 2020 Meta ULC. All rights reserved